The company, which is developing ozone injection technology to treat herniated discs, also recently completed a $520,000 angel financing to pursue certification of its spinal injection system.
Last year, the Minimus raised $1 million from 25 investors.
More Articles on Devices:
Bioventus Leases $5M Office, Creates 44 Jobs
Study: Novel Spine Device Can Improve Osteogenesis Imperfecta
Stryker to Eliminate 1,000 Employees by Year’s End
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.